Selected Balance Sheet Information

9 Months Ended

Sep. 30, 2022

Selected Balance Sheet Information [Abstract]

Selected balance sheet information

3. Selected balance sheet information

Inventory consists of the following at:

	September 30,		December 31,
(in thousands)	2022		2021
Raw material	$	2,139	$	1,593
Work-in-process		917		482
Finished goods		3,008		1,805
	$	6,064	$	3,880

Property and equipment, net consists of the following at:

	September 30,		December 31,
(in thousands)	2022		2021
Office furniture and equipment	$	350	$	271
Lab equipment		2,632		1,565
Computer equipment and software		610		556
Leasehold improvements		95		88
Capital equipment in process		212		813
		3,899		3,293
Less: Accumulated depreciation and amortization		2,152		1,868
	$	1,747	$	1,425

Depreciation expense was $127,000 and $42,000 for the three months ended September 30, 2022 and 2021, respectively, and $284,000 and $112,000 for the nine months ended September 30, 2022 and 2021, respectively.

Accrued expenses consist of the following at:

	September 30,		December 31,
(in thousands)	2022		2021
Bonuses	$	2,048	$	2,028
Clinical trial and other professional fees		1,808		1,607
Paid time off		853		699
Customer rebates		370		380
Operating lease liability, current portion		218		—
Other		823		684
	$	6,120	$	5,398